SK Inc. (034730.KS) Q1 2026: Operating Profit Surges 8.6x to ₩3.67T as HBM Cycle and Oil Refining Rebound Collide
Consolidated operating profit explodes from ₩427B to ₩3.67T on simultaneous peaks at SK Innovation and SK Square — but standalone parent earnings sink 29% and operating cash flow captures just 6.7% of net income.
Source: Q1 2026 Quarterly Report — Filed May 2026 with DART | Consolidated Financial Statements | Unit: ₩ billions
Consolidated operating profit ballooned 8.6-fold in a single quarter — from ₩427 billion to ₩3.67 trillion — and the mechanism is straightforward. The SK Innovation cluster swung from a ₩30.7 billion operating loss to a ₩2.16 trillion profit, while SK Square's operating profit rocketed from ₩1.65 trillion to ₩8.28 trillion as the SK hynix HBM cycle hit full stride. With two subsidiary cycle peaks colliding in the same quarter, consolidated revenue reached ₩36.75 trillion (+18.9%) and net income hit ₩9.91 trillion (+175.9%). Yet SK Inc.'s standalone operating profit actually declined 29.3% from ₩176.2 billion to ₩124.6 billion, and the operating-cash-flow-to-net-income ratio came in at just 0.07x (₩661 billion of operating cash flow against ₩9.9 trillion of net income) — confirming that the bulk of this earnings explosion is non-cash equity-method income. The quarter offers a near-perfect case study in how a Korean holding company shines at the peak of its subsidiary cycle, and what gets obscured in the glare.
Balance Sheet — Assets Jump ₩15.2 Trillion in One Quarter, 60% from Equity-Method Revaluation
Major Asset Movements
| Item | Dec 31, 2025 | Mar 31, 2026 | Change | % Change |
|---|---|---|---|---|
| Cash and cash equivalents | ₩25,214.1B | ₩24,199.1B | -₩1,015.0B | -4.0% |
| Trade receivables | ₩13,133.4B | ₩16,641.2B | +₩3,507.8B | +26.7% |
| Inventories | ₩13,640.5B | ₩14,288.0B | +₩647.5B | +4.8% |
| Property, plant & equipment | ₩69,788.3B | ₩71,194.6B | +₩1,406.3B | +2.0% |
| Intangible assets | ₩8,558.9B | ₩8,462.6B | -₩96.3B | -1.1% |
| Investments in associates & JVs | ₩37,785.8B | ₩47,160.4B | +₩9,374.6B | +24.8% |
| Deferred tax assets | ₩3,514.7B | ₩3,699.4B | +₩184.7B | +5.3% |
| Total assets | ₩213,519.7B | ₩228,766.1B | +₩15,246.4B | +7.1% |
Approximately 61% of the ₩15.2 trillion quarterly asset expansion originated from a single line item: investments in associates and joint ventures. The bulk of that ₩9.37 trillion increase reflects the mark-up in the carrying value of SK Square's SK hynix stake during the quarter. Cross-referencing SK Square's separately filed Q1 2026 report, the carrying value of SK hynix rose from ₩26.18 trillion at year-end to ₩35.02 trillion — an ₩8.84 trillion gain that flowed directly into SK Inc.'s consolidated balance sheet through the equity method.
The 26.7% jump in trade receivables is a normal consequence of the SK Innovation cluster's revenue recovery from ₩21.0 trillion to ₩24.2 trillion (+15.2%), with cash conversion deferred by one to two quarters. The 2.0% rise in PP&E (₩1.4 trillion) aligns precisely with quarterly capex of ₩1.85 trillion, while the ₩96.3 billion decline in intangibles reflects amortization of goodwill and industrial property rights outpacing fresh capitalization.
Retained earnings climbed from ₩13.01 trillion to ₩16.14 trillion — a ₩3.13 trillion (+24.1%) increase reflecting the ₩3.38 trillion owner-attributable net income net of dividends. The ₩1.02 trillion cash drawdown for the quarter resulted from operating cash flow of ₩661 billion plus ₩428 billion of foreign exchange translation inflows being overwhelmed by ₩1.99 trillion of net financing outflows and a ₩32 billion shift in assets held for sale. Cash reserves remain robust at ₩24 trillion.
Debt Structure — Maturity Shortens, Deferred Tax Liability Surges 28%
| Liability Item | Dec 31, 2025 | Mar 31, 2026 | Change | % Change |
|---|---|---|---|---|
| Short-term borrowings | ₩11,714.2B | ₩13,335.4B | +₩1,621.2B | +13.8% |
| Bonds & long-term borrowings | ₩45,546.0B | ₩44,204.3B | -₩1,341.7B | -2.9% |
| Trade payables | ₩13,083.3B | ₩13,217.6B | +₩134.3B | +1.0% |
| Deferred tax liabilities | ₩4,766.8B | ₩6,096.0B | +₩1,329.2B | +27.9% |
| Total liabilities | ₩127,828.3B | ₩131,728.2B | +₩3,899.9B | +3.1% |
Total borrowings held essentially flat, but the composition shifted — non-current bonds and long-term borrowings declined by ₩1.34 trillion while short-term borrowings rose by ₩1.62 trillion, nudging the maturity profile toward the short end. The cash flow statement confirms the rotation precisely: ₩3.20 trillion of new bond and borrowing issuance against ₩5.50 trillion of repayments yields net deleveraging of ₩2.30 trillion, while short-term borrowings posted a net increase of ₩1.41 trillion. On a standalone basis, SK Inc. maintains a debt ratio of 69.48% (down marginally from 69.54%), comfortably below the 200% Fair Trade Act ceiling for holding companies.
The most striking line is the 27.9% surge in deferred tax liabilities — an absolute increase of ₩1.33 trillion. This reflects the accounting recognition of latent capital gains tax on the quarter's ₩8.24 trillion equity-method gain, not an actual cash outflow. The shadow of the earnings boom is thus etched directly into the liability side as well, representing a dormant obligation that converts to a cash tax burden whenever subsidiary stakes are eventually sold.
Capital Structure — Non-Controlling Interest ₩67.5T vs. Controlling Interest ₩29.6T: The Anatomy of the Korean Holding Company Discount
| Capital Item | Dec 31, 2025 | Mar 31, 2026 | Change | % Change |
|---|---|---|---|---|
| Paid-in capital | ₩16.1B | ₩16.1B | 0 | 0.0% |
| Retained earnings | ₩13,011.4B | ₩16,142.1B | +₩3,130.7B | +24.1% |
| Equity attributable to owners | ₩25,187.2B | ₩29,580.1B | +₩4,392.9B | +17.4% |
| Non-controlling interest | ₩60,504.1B | ₩67,457.8B | +₩6,953.7B | +11.5% |
| Total equity | ₩85,691.3B | ₩97,037.9B | +₩11,346.6B | +13.2% |
The ₩11.35 trillion increase in total equity was driven by ₩9.91 trillion of quarterly consolidated net income plus ₩1.61 trillion of other comprehensive income (₩1.77 trillion foreign operations translation gain less ₩290 billion in derivative valuation losses, among other items). The critical observation is the proportion: non-controlling interest of ₩67.5 trillion stands at 2.28x the ₩29.6 trillion attributable to controlling shareholders. Of the ₩11.35 trillion quarterly equity increase, non-controlling interests captured ₩6.95 trillion (61%) while controlling shareholders received ₩4.39 trillion (39%). Of the ₩9.91 trillion quarterly net income, ₩6.53 trillion (66%) belongs to non-controlling shareholders. This structural gap between "what SK Inc. shareholders actually receive" and "the value of the entire SK Group" is captured precisely in these numbers — and it is one of the foundational reasons Korean holding company NAVs typically trade at 40-60% discounts in the market.
Income Statement — 95% of the 8.6x Operating Profit Explosion Came from Two Subsidiaries
Core Earnings Metrics (Q1 2026 vs. Q1 2025 with FY2023-FY2025 Annual Trajectory)
| Item | FY2023 | FY2024 | FY2025 | Q1 2025 | Q1 2026 | YoY (Quarter) |
|---|---|---|---|---|---|---|
| Revenue | ₩127,435B | ₩123,400B | ₩122,703B | ₩30,900B | ₩36,751B | +18.9% |
| Cost of sales | ₩115,443B | ₩112,900B | ₩113,115B | ₩28,642B | ₩31,056B | +8.4% |
| Gross profit | ₩11,992B | ₩10,499B | ₩9,588B | ₩2,258B | ₩5,696B | +152.3% |
| Gross margin | 9.4% | 8.5% | 7.8% | 7.3% | 15.5% | +8.2pp |
| SG&A | ₩7,821B | ₩8,396B | ₩8,488B | ₩2,002B | ₩2,101B | +5.0% |
| Operating profit | ₩4,789B | ₩2,396B | ₩1,818B | ₩427B | ₩3,673B | +759.7% |
| Operating margin | 3.8% | 1.9% | 1.5% | 1.4% | 10.0% | +8.6pp |
| Equity-method income | -₩2,357B | +₩3,811B | +₩8,838B | +₩1,794B | +₩8,242B | +359.4% |
| Financial income | ₩6,893B | ₩6,800B | ₩7,393B | ₩1,606B | ₩3,931B | +144.8% |
| Financial expense | ₩9,381B | ₩10,100B | ₩10,199B | ₩2,585B | ₩4,938B | +91.0% |
| Profit before tax | -₩773B | ₩1,329B | ₩2,637B | ₩1,681B | ₩11,647B | +593.0% |
| Consolidated net income | -₩406B | +₩529B | +₩3,555B | +₩3,591B | +₩9,906B | +175.9% |
| Owner-attributable | n.a. | n.a. | n.a. | ₩2,349B | ₩3,381B | +43.9% |
| Non-controlling interest | n.a. | n.a. | n.a. | ₩1,242B | ₩6,526B | +425.4% |
| EPS (₩) | n.a. | n.a. | n.a. | 42,645 | 61,371 | +43.9% |
The three-year trajectory must come first to anchor the cycle position. Revenue was essentially flat at ₩127.4 trillion, ₩123.4 trillion, and ₩122.7 trillion. Operating profit, however, contracted 62% over the same span — from ₩4.79 trillion to ₩2.40 trillion to ₩1.82 trillion — and operating margin compressed from 3.8% to 1.5%. Weak refining margins and battery subsidiary SK On's losses suppressed group-wide profitability throughout this stretch. That trajectory reversed sharply in Q1 2026, sending quarterly operating margin spiking to 10.0%.
Pre-tax income expanded even more dramatically (+593%). The ₩3.25 trillion gain in operating profit was amplified by a ₩6.45 trillion swing in equity-method income — meaning roughly 70% of the earnings explosion originated from a single line. The simultaneous doubling of both financial income and expense reflects the bidirectional amplification of non-cash items such as foreign exchange translation and derivative valuation.
Subsidiary Segment Operating Profit — SK Square Alone Accounts for 68% of the Unadjusted Sum
| Segment | Q1 2025 (₩B) | Q1 2026 (₩B) | YoY | % of Q1 2026 Sum |
|---|---|---|---|---|
| SK Inc. (Holdings + IT Services) | 176.2 | 124.6 | -29.3% | 1.0% |
| SK Innovation cluster | -30.7 | 2,162.2 | Turnaround | 17.9% |
| SK Telecom cluster | 567.4 | 537.6 | -5.3% | 4.5% |
| SK Square cluster | 1,654.1 | 8,278.3 | +400.5% | 68.5% |
| SK Networks cluster | 16.5 | 33.4 | +102.4% | 0.3% |
| SKC cluster | -74.0 | -28.7 | Loss narrowed | -0.2% |
| SK Ecoplant cluster | 68.4 | 931.4 | +1,261.7% | 7.7% |
| Other | -20.7 | 48.4 | Turnaround | 0.4% |
| Unadjusted sum | 2,357.1 | 12,087.1 | +412.8% | 100.0% |
| Consolidation adjustments | -1,929.8 | -8,414.0 | — | — |
| Consolidated operating profit | 427.3 | 3,673.1 | +759.7% | — |
SK Square's single-handed contribution. The SK Square cluster alone accounts for 68.5% of the unadjusted sum. Nearly all of its ₩8.28 trillion operating profit consists of non-cash gains from equity-method accounting on SK hynix (SK Square's standalone disclosure puts the SK hynix equity-method gain at roughly ₩8.33 trillion), and this same line is the primary reason consolidation adjustments swing to -₩8.41 trillion.
SK Ecoplant's structural step-change. The +1,262% jump at SK Ecoplant reflects the first full quarter following the 2025 absorption mergers of SK Trichem, SK Resonac, SK Materials JNC, and SK Materials Performance, with operating leverage in the semiconductor gases and materials business now manifesting in earnings. Revenue nearly doubled from ₩2.46 trillion to ₩4.90 trillion (+99.3%).
The hidden parent-level weakness. SK Inc.'s standalone operating profit dropped from ₩176.2 billion to ₩124.6 billion (-29.3%). Standalone revenue fell from ₩787.5 billion to ₩715.8 billion (-9.1%), and the IT services segment alone declined from ₩583.0 billion to ₩528.2 billion (-9.4%). The fundamentals of the businesses SK directly controls at the parent level are deteriorating — a reality obscured by the spectacular surface of the consolidated print.
SG&A Discipline — Conservative Cost Control Drives Operating Leverage
Within the ₩8.49 trillion full-year SG&A run rate (FY2025), the quarterly ₩2.10 trillion print represents only a +5.0% rise from the prior-year ₩2.00 trillion. Set against revenue growth of +18.9% and gross profit growth of +152.3%, this is markedly conservative. Translated into operating leverage (DOL), the structure implies that each 1% increase in revenue translates into roughly a 40% increase in operating profit — the classic high-fixed-cost asset signature of refining and battery groups. This leverage cuts both ways, however, embedding the risk of equally sharp downside when the cycle inverts.
Cash Flow — Operating Cash Flow Turns Positive but Captures Just 6.7% of Net Income
| Item | FY2023 | FY2024 | FY2025 | Q1 2025 | Q1 2026 |
|---|---|---|---|---|---|
| Operating cash flow | +₩11,354B | +₩8,320B | +₩6,099B | -₩208B | +₩661B |
| Investing cash flow | -₩21,628B | -₩12,158B | -₩537B | -₩188B | -₩84B |
| Financing cash flow | +₩11,524B | +₩4,875B | -₩5,038B | +₩1,618B | -₩1,987B |
| Capex (PP&E acquisitions) | ₩18,915B | ₩15,673B | ₩9,586B | ₩3,192B | ₩1,852B |
| Capex/Revenue | 14.8% | 12.7% | 7.8% | 10.3% | 5.0% |
| Free cash flow (OCF - Capex) | -₩7,561B | -₩7,353B | -₩3,487B | -₩3,400B | -₩1,191B |
| Dividends paid | ₩1,674B | ₩1,815B | ₩1,544B | ₩61B | ₩18B |
| Consolidated net income | -₩406B | +₩529B | +₩3,555B | +₩3,591B | +₩9,906B |
| OCF / Net income | n.a. | 15.7x | 1.72x | n.a. | 0.07x |
The three-year trajectory makes clear that the SK Group's capital cycle has decisively turned. The 2023 capex peak of ₩18.9 trillion represented the apex of group-wide growth investment — SK On battery, SK Siltron wafers, SK Signet EV charging, SK Pharmteco CDMO — and has since contracted by roughly a third each year, falling to ₩9.6 trillion in FY2025. Q1 2026 stepped down again to ₩1.85 trillion (₩7.4 trillion annualized). In parallel, investing cash flow swung from -₩21.6 trillion to -₩12.2 trillion to nearly zero at -₩0.5 trillion, while financing cash flow reversed direction entirely — from borrowing expansion (+₩11.5 trillion → +₩4.9 trillion) to net repayments (-₩5.0 trillion at the group level, -₩2.0 trillion this quarter). The "rebalancing" strategy that SK Group formally announced in 2024-2025 — divesting non-core assets, rationalizing duplicate investments, restoring financial stability — is now visible directly in the numbers.
The 6.7% ratio of quarterly operating cash flow (₩661 billion) to net income (₩9.91 trillion) deserves separate scrutiny. The primary cause is the non-cash nature of the ₩8.24 trillion equity-method gain. Stripping that line out, "cash-generating base net income" comes to ₩1.67 trillion, against which the OCF/NI ratio rises to 0.40x. The next largest drags are working capital adjustments of -₩4.12 trillion (driven by the ₩3.51 trillion build in receivables) and non-cash item adjustments of -₩4.28 trillion. In substance, the revenue recovery of Q1 has not yet been collected as cash and, under a normal receivables cycle, should convert into operating cash flow over Q2 and Q3.
Free cash flow has been negative for three consecutive years, but the absolute deficit has shrunk by roughly half each year — from -₩7.56 trillion to -₩7.35 trillion to -₩3.49 trillion. The Q1 2026 print of -₩1.19 trillion should be read for trajectory rather than simple quarterly extrapolation, with the most decisive shift being the collapse of capex/revenue from 14.8% to 5.0%. That 5.0% ratio is unlikely to persist indefinitely. Announced investment pipelines remain in place — SK On's U.S. line expansion, SK Siltron's U.S. CSS line, SK Pharmteco CDMO expansion, SK Ecoplant's semiconductor gases capacity buildout — leaving open the possibility of capex re-acceleration in the second half of 2026.
NAV, Contingent Liabilities, and Derivatives — Four Variables That Define the Holding Company Thesis
Standalone NAV — ₩16 Trillion in Book Value, Market Value a Multiple Higher
The aggregate book value of SK Inc.'s standalone holdings in subsidiaries and associates breaks down as follows:
| Subsidiary | Ownership | Book Value (₩B) | Listed |
|---|---|---|---|
| SK Innovation | 52.09% | 6,711.5 | Yes |
| SK Telecom | 30.57% | 2,929.9 | Yes |
| SK Square | 32.14% | 2,486.1 | Yes |
| SK Networks | 43.90% | 706.2 | Yes |
| SKC | 40.64% | 548.7 | Yes |
| SK Ecoplant | 69.05% | 1,270.9 | No |
| SK Biopharm | 50.08% | 288.8 | Yes |
| SK Pharmteco | 100.00% | 1,651.2 | No |
| SK Siltron | 51.00% | 622.6 | No |
| SK Signet | 58.21% | 211.6 | Yes |
| SK China | 27.42% | 557.1 | No |
| Total | — | ~15,984.6 | (Book value basis) |
Book value stands at approximately ₩16 trillion, but applying the same-day SK Square disclosure of SK hynix carrying value at ₩35.02 trillion (under equity-method accounting) and translating through SK Inc.'s 32.14% stake in SK Square yields approximately ₩11.3 trillion attributable to SK Inc. alone from this single look-through. Aggregating SK Innovation's market capitalization, SK Telecom's market capitalization, and SK Pharmteco's IPO option value at market would push standalone NAV to several times book. This analysis does not attempt a specific market-value NAV figure. The standalone debt ratio of 69.48% leaves ample headroom against the 200% Fair Trade Act ceiling, but subsidiary share price volatility flows directly into NAV — a structural feature that does not change.
The quarter's disposal of 10,917,028 SK Biopharm shares (13.94% stake) deserves mention on capital allocation grounds. The pattern of monetizing non-core or post-IPO normalized assets to redeploy cash at the parent is continuing, while the assets-held-for-sale balance moving from ₩8,003.1 billion to ₩8,103.0 billion — effectively flat — indicates that a portfolio rotation is underway in parallel: as one asset is sold, another is moved into the held-for-sale category.
PRS and TRS Derivatives — Parent Settlement Exposure on Subsidiary Share Weakness
Quarter-end standalone derivative liabilities totaled ₩684.4 billion (₩153.7 billion current plus ₩530.7 billion non-current), up ₩38.6 billion from the prior year-end balance of ₩645.8 billion. The notable development is the addition of two new price-return swaps (PRS) during the quarter.
The SK Innovation common share PRS (executed July 30, 2025, three-year tenor) covers 14,414,409 shares with seven SPC counterparties acting as guaranteed-sale counterparties — Double S Ever 2025, MS Partners, and Cube Inno among them. SK pays a fixed periodic return (three-year corporate bond yield plus 1.5 percentage points), and at maturity bears the shortfall if the share price falls below the issue price.
The SK Biopharm common share PRS (executed February 26, 2026, three-year tenor) covers the 10,917,028 shares (13.94%) disposed of during Q1 and was struck with five SPCs including Korea Investment & Securities and Great Double S. The credit spread of 1.15 percentage points is lower than that of the SK Innovation PRS.
Adding the existing two SK Shipping TRS positions (valued at ₩16.9 billion and ₩519.1 billion, each booked under long-term borrowings) brings standalone derivative and TRS exposure to over ₩1 trillion at quarter-end. If SK Innovation, SK Biopharm, or SK Shipping shares undergo meaningful weakness over the three-year horizon, the parent faces direct cash settlement obligations. The -₩290.7 billion derivative valuation loss recorded during the quarter reflects movements in these exposures.
SK Ecoplant and SK Pharmteco RCPS — Contingent Liabilities Tied to IPO Timelines
SK is party to shareholder agreements covering convertible preferred shares issued by subsidiary SK Ecoplant. If SK Ecoplant fails to complete a qualified IPO by the prescribed deadline, SK retains the right — directly or through a third party — to exercise a put option over the entirety of the preferred shares. The company has disclosed that, subsequent to the reporting period, it acquired "a portion" of these preferred shares (Note 33). SK Pharmteco carries an identical structure, with SK obligated to redeem RCPS at a guaranteed return price upon IPO failure and providing payment guarantees. As IPO visibility for either unlisted subsidiary deteriorates, these contingent obligations could convert into parent-level cash burdens. Tracking the remaining preferred share balance and timeline in future quarterly filings is a quantifiable necessity.
AWS 10-Year, USD 1.3 Billion Commitment — The Cost Anchor of the IT Services Segment
In July 2025, SK Inc. entered into a 10-year contract with AWS totaling USD 1.3 billion (approximately ₩1.8 trillion) for cloud services. Simultaneously, SK arranged a back-to-back structure to resupply USD 800 million (approximately ₩1.1 trillion) of AWS services to SK Telecom over the same period. The net USD 500 million difference represents SK Inc.'s own cloud consumption, translating to roughly USD 50 million annually (approximately ₩70 billion) embedded as a fixed cost in the IT services segment for the next decade. This is the first commitment that quantifies the cost anchor of the company's "AI Default" transition and warrants tracking as a key indicator of when the IT services segment's operating margin can recover.
Standalone IT Services — Revenue Down 9.4%, Order Backlog of ₩341.5 Billion
Of the quarter's ₩528.2 billion in IT services revenue, systems integration and operations/maintenance contributed ₩483.4 billion (91.5%, domestic plus export), and hardware merchandise contributed ₩44.9 billion (8.5%) — a structure centered on SI and ITO. Examining the year-over-year revenue mix, hardware merchandise exports fell from ₩436.3 billion in FY2024 to ₩177.1 billion in FY2025 to just ₩13.6 billion in Q1 2026, while domestic hardware similarly contracted from ₩268.8 billion in FY2025 to ₩31.3 billion in Q1 2026. The segment is in the middle stage of transitioning away from proprietary hardware resale and toward cloud and outsourcing services. New orders of ₩373.2 billion during the quarter (excluding affiliate outsourcing) yielded ₩31.7 billion of recognized revenue and a backlog of ₩341.5 billion — equivalent to 65% of quarterly revenue. Visibility on Q2 revenue at roughly the average quarterly pace is therefore secured, but whether the -9.4% revenue decline is transitory or trend-line requires confirmation through Q2 and Q3 new order flow. Against the domestic IT services market of ₩32.8 trillion (Gartner 2026), SK's IT services segment at ₩2.75 trillion in FY2025 revenue represents approximately 8-9% market share.
Key Findings
Two distinct growth engines drove the headline numbers. The SK Innovation cluster turned its prior-year operating loss into a ₩2.16 trillion profit on the back of successive consolidations — SK E&S (November 2024), SK enmove (November 2025), SK Trading International, and SK Entum — combined with a simultaneous recovery in refining, LNG, and power generation margins. Meanwhile, SK Square posted a 400% jump in operating profit, almost entirely attributable to the SK hynix HBM cycle peak flowing through equity-method accounting.
The quality of consolidated earnings divides into two distinct layers. Headline metrics (₩3.67 trillion consolidated operating profit, ₩9.91 trillion net income) reflect a quarterly high formed by the collision of the SK hynix HBM peak and the SK Innovation turnaround. Yet cash flow (₩661 billion of OCF) and parent-level standalone operating profit (₩124.6 billion, -29.3%) point in the opposite direction.
The non-controlling interest weight is structurally large. Of the ₩9.91 trillion in consolidated net income, ₩6.53 trillion (66%) accrued to non-controlling shareholders rather than SK Inc. shareholders. With non-controlling interest at 2.28x controlling interest on the balance sheet, the dilution of consolidated earnings into per-share value at the parent level remains a defining feature — and a structural anchor of the persistent holding company discount.
The contingent obligations are larger than the headline derivative liability suggests. The two new PRS positions on SK Innovation and SK Biopharm, combined with legacy SK Shipping TRS exposure, lift total standalone derivative and TRS exposure above ₩1 trillion. Layered on top are RCPS put/call obligations tied to the IPO timelines of SK Ecoplant and SK Pharmteco, both of which would convert into parent-level cash demands if subsidiary listings slip.
The deferred tax liability buildup is a hidden footprint of the earnings boom. The ₩1.33 trillion (+28%) jump in deferred tax liabilities reflects pre-recognition of latent capital gains tax on the ₩8.24 trillion equity-method gain. While this is a non-cash item today, it crystallizes into a real cash tax burden whenever the underlying subsidiary stakes are monetized — a consideration that materially affects the disposal economics of any future portfolio rationalization.
Outlook
The bull thesis rests on the continued momentum of the SK hynix HBM cycle flowing through SK Square equity-method accounting, the durability of the SK Innovation cluster's turnaround as refining, LNG, and power margins normalize at higher levels, the maturation of SK Ecoplant's semiconductor materials and gases business following the 2025 absorption mergers, and the cumulative payoff of the multi-year capex compression that has dropped capex/revenue from 14.8% to 5.0%. The rebalancing strategy is producing tangible balance sheet improvement, free cash flow deficits have narrowed by roughly half each year, and announced asset disposals are creating optionality for capital return to parent shareholders.
The risks are equally specific. The 0.07x OCF-to-net-income ratio is a direct warning that the headline earnings explosion is overwhelmingly non-cash equity-method recognition rather than distributable subsidiary cash flow. The HBM cycle, while currently at peak, is cyclical by definition — and the operating leverage that magnified earnings 8.6x on the upside cuts equally sharply on the downside. SK Inc.'s standalone operating profit declined 29.3% year-over-year, and the 9.4% drop in IT services revenue may signal something more durable than a single-quarter effect pending Q2 and Q3 confirmation. Contingent obligations from PRS, TRS, and RCPS structures could convert into cash demands if subsidiary share prices weaken or IPO timelines slip. Capex is likely to re-accelerate in the second half of 2026 as SK On's U.S. expansion, SK Siltron's CSS line, SK Pharmteco's CDMO buildout, and SK Ecoplant's capacity additions advance from announcement to construction phase. The path of SK On's profitability inflection remains the largest single variable for second-half consolidated results.
This analysis is based on SK Inc.'s (034730) Q1 2026 quarterly report filed with the Financial Supervisory Service via DART. This content does not constitute investment advice or a solicitation to buy or sell securities. Securities investment involves the risk of principal loss, and all final investment decisions are the sole responsibility of the investor.
